We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+1.19%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$186M
AUM Growth
+$12.3M
Cap. Flow
+$12.3M
Cap. Flow %
6.63%
Top 10 Hldgs %
27.45%
Holding
623
New
80
Increased
200
Reduced
184
Closed
42

Sector Composition

Rank Sector Weight
1 Technology 9.76%
2 Consumer Discretionary 7.16%
3 Healthcare 6.95%
4 Financials 6.44%
5 Consumer Staples 3.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GS icon
151
Goldman Sachs
GS
$295B
$285K 0.15%
495
+1
+0.2% +$558
FMS icon
152
Fresenius Medical Care
FMS
$13.4B
$284K 0.15%
12,828
-4,458
-26% -$96.8K
CYBR
153
DELISTED
CyberArk
CYBR
$284K 0.15%
846
+199
+31% +$60.5K
NICE icon
154
Nice
NICE
$6.13B
$275K 0.15%
1,621
+1,113
+219% +$198K
DDOG icon
155
Datadog
DDOG
$94.3B
$273K 0.15%
1,899
-32
-2% -$4.39K
DBMF icon
156
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.02B
$272K 0.15%
10,318
+7,351
+248% +$200K
ITA icon
157
iShares US Aerospace & Defense ETF
ITA
$14.1B
$269K 0.14%
1,857
-308
-14% -$46.4K
PFF icon
158
iShares Preferred and Income Securities ETF
PFF
$13.2B
$258K 0.14%
8,119
-785
-9% -$25.6K
SCHW
159
Charles Schwab
SCHW
$185B
$253K 0.14%
3,431
+46
+1% +$3.44K
SWK icon
160
Stanley Black & Decker
SWK
$14.5B
$247K 0.13%
3,096
+324
+12% +$30K
CWB icon
161
State Street SPDR Bloomberg Convertible Securities ETF
CWB
$5.46B
$246K 0.13%
+3,152
New +$249K
TFC icon
162
Truist Financial
TFC
$64.4B
$245K 0.13%
5,659
+531
+10% +$23.7K
PFE icon
163
Pfizer
PFE
$144B
$245K 0.13%
9,202
+1,086
+13% +$29.5K
VWO icon
164
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$245K 0.13%
5,572
-4,141
-43% -$192K
FPEI icon
165
First Trust Institutional Preferred Securities and Income ETF
FPEI
$1.92B
$245K 0.13%
+13,054
New +$246K
AXP icon
166
American Express
AXP
$226B
$244K 0.13%
819
+44
+6% +$12.6K
HYHG icon
167
ProShares High Yield-Interest Rate Hedged ETF
HYHG
$183M
$244K 0.13%
+3,738
New +$244K
HYS icon
168
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.74B
$244K 0.13%
+2,595
New +$245K
IBN icon
169
ICICI Bank
IBN
$107B
$241K 0.13%
8,098
-8
-0.1% -$242
WMB icon
170
Williams Companies
WMB
$85.8B
$241K 0.13%
4,309
-122
-3% -$6.58K
VZ icon
171
Verizon
VZ
$201B
$238K 0.13%
5,912
+140
+2% +$5.91K
DUK icon
172
Duke Energy
DUK
$101B
$232K 0.13%
2,154
+210
+11% +$23.8K
BRK.B icon
173
Berkshire Hathaway Class B
BRK.B
$1.1T
$231K 0.12%
513
+31
+6% +$14.3K
NLR icon
174
VanEck Uranium + Nuclear Energy ETF
NLR
$3.7B
$227K 0.12%
2,683
+1,721
+179% +$154K
ETN icon
175
Eaton
ETN
$141B
$223K 0.12%
671
-1
-0.1% -$351

Similar funds

Castleview Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Castleview Partners held 623 positions worth $186M, up 7.1% from $173M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Castleview Partners deployed $12.3M of net new capital in Q4 2024, opening 80 new positions and adding to 200 existing holdings. Its largest new stake was ConocoPhillips: 28,165 shares worth $2.82M.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, down from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was VanEck CLO ETF, an estimated $594K trimmed.

  • Castleview Partners's largest Q4 2024 buy was ConocoPhillips: 28,165 shares worth $2.82M.
  • Castleview Partners added most to VanEck AA-BB CLO ETF in Q4 2024, an estimated $930K increase.
  • Castleview Partners's biggest Q4 2024 reduction was VanEck CLO ETF, cutting an estimated $594K.
  • Castleview Partners fully exited YieldMax Ultra Option Income Strategy ETF in Q4 2024, selling an estimated $627K.
  • Castleview Partners's ten largest holdings make up 27% of its $186M portfolio in Q4 2024.
  • Castleview Partners opened 80 new positions and closed 42 in Q4 2024.
  • Castleview Partners's portfolio value rose 7.1% quarter-over-quarter to $186M.

Based on Castleview Partners's 13F filing for Q4 2024, filed 21 Jan 2025.